Consistent with our results, studies showed that RPS6 was overexpression in non-small cell lung cancer [13], esophagus squamous cell carcinoma [15], pancreatic neuroendocrine tumors [31] and sarcoma [32]. The gene discussed is RPS6; the disease is pancreatic neuroendocrine tumor.